Seizures and cancer;Epilepsie et cancer

Revue de Medecine Interne

Volumn 19, Issue 5, 1998, Pages 325-333

  Lebrun, C ^a   Thomas, P ^a   Peyrade, F ^b   Frenay, M ^c  

^a PASTEUR HOSPITAL   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Cancer; Chemotherapy; Epilepsy; Radiotherapy

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; ASPARAGINASE; BENZODIAZEPINE DERIVATIVE; BUSULFAN; CARBAMAZEPINE; CARMUSTINE; CISPLATIN; CLONAZEPAM; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DIAZEPAM; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GABAPENTIN; IFOSFAMIDE; INTERLEUKIN 2; ISONIAZID; LAMOTRIGINE; MESNA; METHOTREXATE; NITROSOUREA DERIVATIVE; PACLITAXEL; PHENOBARBITAL; PHENYTOIN; PROCARBAZINE; PSYCHOTROPIC AGENT; SEDATIVE AGENT; TAXANE DERIVATIVE; THEOPHYLLINE; TIAGABINE; VALPROIC ACID; VIGABATRIN; VINCRISTINE;

ANTICONVULSANT THERAPY; BRAIN TUMOR; CANCER; DISEASE CLASSIFICATION; DRUG MONITORING; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUMBAR PUNCTURE; METABOLIC DISORDER; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC SYNDROME; RADIATION INJURY; RADIODENSITOMETRY; REVIEW; SYMPTOMATOLOGY;

EID: 0031776061     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(98)80102-1     Document Type: Article

References (41)

1. Gilbert MR, Grossman SA. Incidence and nature of neurologic problems in patients with solid tumors. Am J Med 1986 ; 81 : 951-4
2. Shirts SB, Annegers JF, Hauser WA, Kurland LT. Cancer incidence in a cohort of patients with seizure disorders. J Natl Cancer Inst 1986 ; 77 : 83-7
3. Berger MS, Keles E. Epilepsy associated with brain tumors. In: Brain tumors. New York: Churchill Livingstone; 1995. p 239-46
4. Manford M, Hart YM, Sander J, Shorvon SD. National general practice study of epilepsy (NGPSE): Partial seizure patterns in a general population. Neurology 1992 ; 42 : 1911-7
5. Penfield W, Erickson TC, Tarlov IM. Relation of intracranial tumors and symptomatic epilepsy. Arch Neurol Psychiatr 1940 ; 44 : 300-15
6. Franceschetti S, Binelli S, Casazza M, Lodrini S, Punzica F, Pluchino F, et al . Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumors. Acta Neurochir (Wien) 1990 ; 103 : 47-51
7. Commission on classification and terminology of the international league against epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epitepsia 1981 ; 22 : 489-501
8. Thomas P, Genton P. Epilepsies. Paris : Masson ; 1993
9. Loiseau P, Jallon P. Dictionnaire analytique d'épileptologie clinique. Paris : John Libbey ; 1990
10. Mc Donald DR. Neurotoxicity of chemolherapeutic agents. In: Perry MC, ed. The chemotherapy source book. Baltimore: Williams and Wilkins; 1992. p 666-79
11. Paillas JE. A review of 2413 tumours operated over a 30-year period. J Neuroradiol 1991 ; 18 : 79-106
12. Gonzales D, Elvidge AR. On the occurrence of epilepsy caused by astrocytomas of the cerebral hemispheres. J Neurosurg 1962 ; 19 : 470-82
13. Delarive J, De Tribolet N. Métastases cérébrales. Étude d'un collectif chirurgical de 81 cas. Neurochirurgie 1992 ; 38 : 89-97
14. Cappelaere P, Dubois F. Complications neurologiques de la chimiothérapie. In : Tumeurs du système nerveux et de ses enveloppes. Paris : Flammarion Médecine-Sciences ; 1989. p 802-10
15. Baker WJ, Royer GL. Weiss RB. Cytarabine and neurologic toxicity. J Clin Oncol 1991 ; 9 : 679-93
16. Burger PC, Kamenar E, Schold SC, Fay JW, Phillips GL, Herzig GP. Encephalopathy following high-dose BCNU therapy. Cancer 1981, 48 : 1318-27
17. Dimaggio JR, Brown R, Baile WF, Schapira D. Hallucinations and Ifosfamide-induced neurotoxicity. Cancer 1994 ; 73 : 1509-14
18. Pratt CB, Green AA, Horowitz ME, Meyer WH, Etcubanas E, Douglass E et al . Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna. J Clin Oncol 1986 ; 4 : 1253-61
19. Merimsky O, Reider-Groswasser I, Wigler N, Chaitchik S. Encephalopathy in ifosfamide-treated patients. Acta Neurol Scand 1992 ; 86 : 521-5
20. Kupfer A, Aeschlimann C, Wermuth B, Cerny T. Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue. Lancet 1994; 343 : 763-4
21. Onetto N, Dougan M, Hellmanns et al . Safety profile. In: Paclitaxel in cancer treatment. William, Me Guire WP, Rowinsky E, eds. New York: Marcel Dekker, Inc; 1995. p 135-8
22. Mollman JE. Cisplatin neurotoxicity. N Engl J Med 1990 ; 322 : 126-7
23. Lindeman G, Kefford R, Stuart-Harris R. Cisplatin neurotoxicity. N Engl J Med 1990 ; 323 : 64
24. Highley M, Meller ST, Pinkerton CR. Seizures and cortical dysfunction following high-dose cisplatin administration in children. Med Pediatr Oncol 1992 ; 20 : 143-8
25. Crosley CJ, Rorke LB, Evans A, Nigro M. Central nervous system lesions in childhood leukemia. Neurology 1978 ; 28 : 678-85
26. Kubo M, Azuma E, Arai S, Komada Y, Ito M, Sakura M. Transient encephalopathy following a single exposure of high-dose methotrexate in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1992 ; 9 : 157-65
27. Murphy CP, Harden EA, Thompson JM. Generalized seizures secondary to high-dose busulfan therapy. Ann Pharmacother 1992 ; 26 : 30-1
28. Hassan M, Oberg G, Bjorkhom M, Wallin I, Lingren M. Influence of prophylactic anticonvulsivant therapy on high-dose busulphan kinetics. Cancer Chemother Pharmacol 1993 ; 33 : 181-6
29. Patchell RA, White CL, Clark AW, Beschorner WE, Santos GW. Neurologic complications of bone marrow transplantation. Neurology 1985 ; 35 : 300-6
30. Snider S, Bashir R, Bierman P. Neurologic complications after high-dose chemotherapy and autologous bone marrow transplatation for Hodgkin's disease. Neurology 1994 ; 44 : 681-4
31. Bocci V. Central nervous system toxicity of Interferons and other cytokines. J Biol Regul Homeost Agents 1988 ; 3 : 107-8
32. Peyrade F, Lebrun C, de Jaureguiberry JP, Taillan B, Jaubert D, Dujardin P. Perte de connaissance au cours d'un traitement par G-CSF. Rev Méd Interne 1997 ; 18 : 822-3
33. Kastru PO, Diener HC. Granulocyte-stimulating factor filgastrim and molgramostrim induced recurring encephalopathy and focal status epilepticus. J Neurol 1997 ; 244 : 274-5
34. Chevenet C, Ferrier MC, Reverte M, Tao Y, Perea R, Rolier H et al . Erythema multiforme caused by the combination of carbamazepine and cerebral irradiation. Ann Dermatol Vénéréol 1992 ; 119 : 929-31
35. Rowe JE, Pina J, Sau P, Samlaska C, James W. Toxic epidermal necrolysis associated with diphenylhydantoin and cranial irradiation. Int J Dermatol 1991 ; 30 : 747-9
36. Gregory RE, Grossman S, Sheidler VR. Grand mal seizures associated with high-dose intravenous morphine infusions: incidence and possible etiology. Pain 1992 ; 51 : 255-8
37. Delattre JY, Davila I, Vega F, Poisson M. Auto-immunité et syndromes neurologiques paranéoplasiques. Rev Neurol 1991 ; 147 : 546-9
38. Honnorat J. Anticorps antineuronaux et syndromes neurologiques paranéoplasiques. La Leure du Neurologue 1997 ; 2 : 49-53
39. Smith DF, Hutton JL, Sandemann D, Foy PM, Shaw MD, Williams IR et al. The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management. J Neurol Neurosurg Psychiatry 1991 ; 54 : 915-20
40. Ribaric II. Excision of two and three independent and separate ipsilateral potentially epileptogenic cortical areas. Acta Neurochirurgica 1984 ; Suppl 33 : 145-8
41. Levy R, Dreifuss FE, Mattson RH, Meldrum BS, Penry JK, eds. Aral epileptic drugs. 3rd ed. New York: Raven Press; 1989